Intended Use

The OptiMap System is used to analyze electrogram (EGM) signals and display results in a visual format for evaluation by a physician in order to assist in the diagnosis of complex cardiac arrhythmias.

Technology

The system consists of hardware components including an Amplifier, Cart, Monitor, and a Workstation with proprietary mapping software. It uses signals from a 64-electrode unipolar mapping basket catheter, transforming time-domain waveforms into spatial Electrographic Flow vectors and Activation Cycle Path maps for visualizing electrical activity in the atria during arrhythmias.

Performance

Software verification and validation testing demonstrated that the OptiMap System Version 1.3 software performs as designed at unit, integration, and system levels. Cybersecurity testing was also completed per FDA guidance. The device met all acceptance criteria and is suitable for intended use with no unresolved issues.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    4/30/2025

    28 days
  • 2

    FDA Approval

    5/28/2025

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.